This webinar focused on men with high-risk prostate cancer and a clinical trial called EvoPAR-Prostate02. The discussion was led by Dr. Keith Crawford with guest expert Dr. Rana McKay, a genitourinary medical oncologist who treats prostate, kidney, bladder, and testicular cancers.
The goal was to help patients understand four main points:
- What high-risk prostate cancer means
- Why BRCA1 and BRCA2 testing may matter
- How PARP inhibitors may work
- What to ask before joining the EvoPAR-Prostate02 clinical trial
What does “high-risk prostate cancer” mean?
High-risk prostate cancer does not always mean the cancer has spread to distant parts of the body.
It means the cancer has … Read More
